Mablink Bioscience

Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).

Domain

mablink.com

Country

France

Employees

11-50

Last Funding

$30.1M

Founded

2017

Frequently Asked Questions

What technologies does Mablink Bioscience use?+

Mablink Bioscience uses 10 technologies including Adobe Client Data Layer, Adobe Experience Manager Franklin, Adobe Experience Platform Launch.

What industry is Mablink Bioscience in?+

Mablink Bioscience operates in the Biotechnology industry.

Where is Mablink Bioscience based?+

Mablink Bioscience is headquartered in France.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: July 2026